Gallbladder Organoids for Precision Drug Toxicity Screening

The gallbladder plays an important role in digestion but hasn’t received much attention in medical research. However, that’s starting to change. With advances in stem cell technology, scientists can now grow miniature, functional models of humans in the lab known as organoids.

These organoids are powerful tools in precision medicine, making it possible to study how different people respond to treatments and drugs more safely. So, what are organoids in precision medicine, and how are they helping researchers better understand drug toxicity and disease?

Understanding Gallbladder Function and Disease

The gallbladder is a small, pear-shaped organ just beneath the liver. The liver produces bile, an essential digestive fluid, which the gallbladder stores. After you eat, the gallbladder releases bile into the small intestine, where it helps your body break down fats. Though small, the gallbladder is crucial for digestion, especially when processing high-fat meals.¹

Gallbladder diseases are more common than many people realize. Gallstones — hardened deposits of cholesterol or bile salts — can block the flow of bile and cause pain, nausea, or infection. Other conditions include inflammation of the gallbladder — also known as cholecystitis — and gallbladder cancer.²

Gallbladder cancer and other biliary cancers are relatively rare, making up about 0.7% of all new cancer diagnoses in the United States.³ However, these diseases can be difficult to diagnose early and may require surgery — such as gallbladder removal — if symptoms become severe.

Understanding how the gallbladder works and what happens when it malfunctions is essential for developing better treatments. That’s where models like organoids come in. They mimic the behavior of real gallbladder tissue and give researchers a more accurate way to test how drugs might affect this specific organ.

What Are Organoids in Precision Medicine?

Organoids are three-dimensional clusters of cells grown in the lab that mimic the structure and function of real organs. They’re created from stem cells and can develop into miniature versions of tissues like the brain, liver, or gallbladder. These lab-grown models allow researchers to study how organs work in a controlled environment without relying on animal models or human samples.⁴

This provides a few benefits. "Organoids have advantages over mouse systems or rodent systems because it's the human genes that are involved in the cells in these organoids and many drugs work on aspects of the genome which are different between humans and other species," Dr. Michelle Lazar, MD, PhD, a professor in Diabetes and Metabolic Diseases at Penn Medicine, told Minnesota Public Radio.⁵ [SOURCE: https://newsnetwork.mayoclinic.org/discussion/new-podcast-organoids-a-powerful-tool-for-individualized-medicine/]

In precision medicine, organoids can be made from a specific person’s cells, meaning healthcare providers and scientists can test how that individual might respond to different drugs. This approach helps avoid trial-and-error treatments and increases the chance of finding the right therapy faster. This could mean more effective and safer care for people with rare or hard-to-treat conditions.⁴

Using organoids also helps identify toxic side effects earlier in drug development. Because the cells behave much like they do in the human body, researchers can observe real medication responses before they reach a clinical trial.⁴ This reduces the risk of unexpected reactions and helps bring safer drugs to the market.

Organoids in precision medicine help personalize treatment, improve drug safety, and open new doors in disease research. As technology evolves, organoids are becoming a central part of how healthcare professionals tailor healthcare to the individual, right down to the cellular level.

Gallbladder Organoids as a New Research Tool

Gallbladder organoids offer a new way to study this organ in detail and test how it responds to different drugs. Here’s how it’s changing the medical field.

Building Mini Gallbladders in the Lab

Gallbladder organoids are typically derived from adult stem cells or reprogrammed cells, which are then cultured in a specialized environment that mimics the body. These cells self-organize into complex structures that maintain many of the same features of a natural gallbladder — such as epithelial cell types, bile transport properties, and gene expression patterns.⁶

What makes them unique is their ability to replicate the physical architecture and function of the gallbladder, something that traditional flat cell cultures or animal models often fail to do. They can even be maintained for long periods, allowing researchers to study chronic disease progression and cellular response over time.

Modeling Disease More Accurately

Gallbladder diseases — like gallstones, cholecystitis, and gallbladder carcinoma — are often under-researched due to the difficulty of accessing fresh, healthy tissue. Organoids solve this problem. By using cells from people with known gallbladder conditions, scientists can create disease-specific organoid models to explore how these illnesses develop at the cellular level.

For example, gallbladder organoids can help researchers observe how inflammation affects epithelial cell integrity or how cholesterol metabolism contributes to stone formation. They also allow gene editing techniques to be applied in a controlled environment. This makes it possible to test the impact of specific mutations linked to gallbladder dysfunction, creating a path to understanding disease mechanisms and identifying potential targets for treatment.⁶

A Safer Way to Test Drugs

Drug-induced gallbladder toxicity is a concern, yet it’s often missed during preclinical testing. Most early-stage drug screenings focus on the liver and kidneys, overlooking the biliary system. Gallbladder organoids fill the gap. They offer a scalable, human-relevant platform to test how compounds affect the gallbladder specifically — before those drugs reach human trials.⁷

By exposing these organoids to experimental drugs, researchers can monitor real-time cellular responses such as bile acid regulation, epithelial barrier integrity, and inflammatory signaling. This approach helps identify harmful side effects early on and supports more precise dosing and safety guidelines.

Drug Toxicity Screening With Gallbladder Organoids

Drug toxicity is one of the leading causes of failure in clinical trials and post-market drug withdrawals. While toxicity testing traditionally focuses on major organs like the liver, kidneys, and heart, scientists often overlook the gallbladder. This is a significant blind spot — especially for drugs processed through the liver and secreted into bile.

Because they replicate the structure and function of real gallbladder tissue, organoids provide a biologically relevant platform to detect harmful effects before a drug reaches human testing. Researchers can expose these models to candidate compounds and observe how the cells respond.⁸ Are there signs of inflammation? Does bile secretion change? Is the epithelial barrier compromised? These are the kinds of questions gallbladder organoids can help answer.

One key advantage is their ability to reflect patient-specific responses.⁸ When organoids are derived from individuals with known sensitivities or gallbladder disease, they can be used to test how genetic or environmental factors influence toxicity. This opens the door to more precise safety profiling for new drugs and existing medications being repurposed or combined in new ways.

Moreover, gallbladder organoids can be integrated into high-throughput drug screening pipelines. This means researchers can test dozens or even hundreds of compounds quickly and efficiently, all while reducing reliance on animal models. As a result, researchers get faster, more accurate toxicity data, and patients get safer, better-targeted treatments.

Challenges and Limitations in Gallbladder Organoid Research

While gallbladder organoids offer exciting possibilities for precision medicine and drug safety, the technology is still developing. Several scientific and practical challenges remain before these models can be fully integrated into mainstream research or clinical practice.

Lack of Standardization

Most organoid systems don’t yet have universally accepted protocols or regulations.⁹ Small variations in how the cells are produced, cultured, or maintained can lead to big structural and functional differences. This lack of standardization makes it harder to compare results between studies or build reproducible datasets that pharmaceutical companies and regulatory bodies can rely on.

Incomplete Cellular Representation

Most gallbladder organoid models are made up primarily of epithelial cells — the main lining of the gallbladder. However, the organ also relies on other important cell types, such as immune cells, nerve fibers, and connective tissue cells. Without these components, organoids may not fully reflect the complexity of gallbladder disease, especially inflammation, pain, or fibrosis.

Cost and Scalability

Creating organoids isn’t cheap or simple and takes time. It requires specialized materials, trained staff, and time-intensive lab work.¹⁰ This makes large-scale drug screening or routine clinical use difficult. Researchers are working on ways to automate and scale up organoid production, but cost and efficiency remain barriers.

Gaps in Gallbladder Biology

Compared to other digestive organs, the gallbladder is still poorly understood. There are questions about its signaling pathways, interaction with the microbiome, and genetic factors contributing to disease. These knowledge gaps limit how far current organoid models can go. More foundational research is needed to guide the development of next-generation organoids.

The Future of Gallbladder Organoid Research

Gallbladder organoid research is still in its early stages, but the potential is vast. As protocols become more refined and reproducible, these organoids may play a central role in uncovering the unique biology of the gallbladder — from understanding how it responds to environmental toxins to exploring its connection to metabolic and gastrointestinal diseases.

One exciting direction is the use of gallbladder organoids in precision medicine. By generating organoids from people with gallbladder disorders, researchers can study disease progression and drug response individually. This could lead to more effective targeted therapies that are less invasive than current treatment options, which often involve full organ removal.⁶

Scientists may also use gallbladder organoids with other organoid systems, such as liver or intestinal models. This would allow researchers to simulate interactions across the digestive system, creating a more complete picture of how drugs, bile acids, and microbiota influence one another.

In time, researchers may be able to model complex scenarios like bile duct obstruction or the effect of gut-liver-gallbladder axis imbalances — all from patient-derived cells in a lab dish. With continued bioengineering and imaging advances, gallbladder organoids could become a standard tool in academic and pharmaceutical research.

The Role of Gallbladder Organoids in Precision Medicine

Gallbladder organoids are opening new doors in biomedical research. They provide a practical way to study gallbladder function, test drug safety, and explore disease mechanisms using models that closely reflect real human tissue. While the field is still developing, the potential is clear. With further refinement, gallbladder organoids could become a valuable part of drug development and personalized treatment strategies.

References

1. Jones MW, Small K, Kashyap S, Deppen JG. Physiology, gallbladder. StatPearls - NCBI Bookshelf. Published May 1, 2023. https://www.ncbi.nlm.nih.gov/books/NBK482488/
2. What to do about gallstones. Harvard Health. Published July 20, 2023. https://www.health.harvard.edu/womens-health/what-to-do-about-gallstones
3. Cancer Awareness – Gallbladder Cancer Facts - Biocare Medical. Biocare Medical. Published March 22, 2024. https://biocare.net/blog/cancer-awareness-gallbladder-cancer-facts/
4. Yang S, Hu H, Kung H, et al. Organoids: The current status and biomedical applications. MedComm. 2023;4(3). doi:10.1002/mco2.274 
5. Gallagher C. New podcast: ‘Organoids – A Powerful Tool for Individualized Medicine’ Mayo Clinic News Network. Published May 1, 2024. https://newsnetwork.mayoclinic.org/discussion/new-podcast-organoids-a-powerful-tool-for-individualized-medicine/ 
6. Nagao M, Fukuda A, Kashima H, et al. Cholangiocyte organoids for disease, cancer, and regenerative medicine. European Journal of Cell Biology. 2024;104(1):151472. doi:10.1016/j.ejcb.2024.151472 
7. Dutta A, Chowdhury N, Chandra S, Guha P, Saha V, GuhaSarkar D. Gallbladder cholangiocyte organoids. Biology of the Cell. 2025;117(2). doi:10.1111/boc.202400132
8. Park SH, Sun W. Toxicity assessment using neural organoids: innovative approaches and challenges. Toxicological Research. 2025;41(2):91-103. doi:10.1007/s43188-025-00279-y
9. Jiang X, Oyang L, Peng Q, et al. Organoids: opportunities and challenges of cancer therapy. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1232528
10. Tran T, Song CJ, Nguyen T, et al. A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery. Cell Stem Cell. 2022;29(7):1083-1101.e7. doi:10.1016/j.stem.2022.06.005